Bristol-Myers Squibb to set up $100 million S&T Innovation Centre in Hyderabad

Biopharma major Bristol-Myers Squibb inks MoU with Telangana government for the facility that will help expand drug development, digital innovation capabilities, employ 1,500 people

Published - February 23, 2023 12:07 pm IST - HYDERABAD

Industries and IT Minister K.T.Rama Rao, BMS Executive V-P Samit Hirawat with officials of State government and the company in Hyderabad on February 23.  

Industries and IT Minister K.T.Rama Rao, BMS Executive V-P Samit Hirawat with officials of State government and the company in Hyderabad on February 23.   | Photo Credit: Special Arrangement

Bristol-Myers Squibb has decided to set up a science and technology innovation centre with an investment of $100 million in Hyderabad to expand its global drug development and digital innovation capabilities.

This will be the biopharmaceutical major’s first such facility in India and help develop capabilities in several areas associated with drug development, from regulatory, biostatistics, operations to clinical sciences, Executive V-P and Chief Medical Officer, Global Drug Development, Samit Hirawat said while a MoU was signed with the Telangana government in the presence of Industries and IT Minister K.T. Rama Rao in Hyderabad on Thursday, February 23.

“As we think about our global presence one of the missing pieces is to be in India, where there is a burgeoning ecosystem from a healthcare perspective, amazing talent,” he said, adding that there there has been an amazing transformation in Hyderabad’s landscape over the last 4-5 years. “When we brought the team here in January and went back, there was no question in our mind on the place to be,” he added.

To invest $100 million over the next 3 years

BMS plans to begin operations of the facility by 2023, which will employ around 1,500 people. On the investment, he said it will $100 million over the next three years. While BMS has a commercial presence and also operates in association with other companies in the country, with the centre it will be marking its presence from a drug development perspective in India, he said.

Elaborating on the proposed work, Dr. Hirawat said the 1,500 people, to be hired over the next three years, will be a diverse set of talent pool ranging from specialisation in information technology, medical writing, regulatory process and statistical programmers, operations besides physicians. The facility, which is likely to be named Science and Technology Innovation Centre, “will help our global drug development process as well as IT processes,” he said, adding over time it can evolve into many functions.

On the location in Hyderabad, he said the process is underway and expected to be completed by third quarter of the year.

Welcoming BMS to the vibrant Life Sciences ecosystem of the city, the Minister urged the company to explore the prospects of setting up a manufacturing facility. The State government is in the process of setting up Hyderabad Pharma City, which will be one of the largest pharma clusters globally, Mr. Rao said.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in


Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.